Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 23;2013(2):1-19.
doi: 10.5339/qmj.2013.10. eCollection 2013.

Concise review of recent studies in vitiligo

Mohamed Allam  1 , Hassan Riad  2
Affiliations
Review

Concise review of recent studies in vitiligo

Mohamed Allam et al. Qatar Med J. .

Abstract

Vitiligo is an acquired pigmentry disorder of the skin and mucous membranes which manifests as white macules and patches due to selective loss of melanocytes. Etiological hypotheses of vitiligo include genetic, immunological, neurohormonal, cytotoxic, biochemical, oxidative stress and newer theories of melanocytorrhagy and decreased melanocytes survival. There are several types of vitiligo which are usually diagnosed clinically and by using a Wood's lamp; also vitiligo may be associated with autoimmune diseases, audiological and ophthalmological findings or it can be a part of polyendocrinopathy syndromes. Several interventions are available for the treatment for vitiligo to stop disease progression and/or to attain repigmentation or even depigmentation. In this article, we will present an overall view of current standing of vitiligo research work especially in the etiological factors most notably the genetic components, also, types and associations and various and newer treatment modalities.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Treatment algorithm for vitiligo. The treatment order was determined by the level of evidence in the literature for each treatment.
See this image and copyright information in PMC

References

    1. Picardo M. Taiieb A: Vitiligo. Heidelberg: Springer; 2010.
    1. Birlea SA, Spritz RA. Norris DA: Vitiligo Wolff K, ed. Fitzpatric's Dermatology in General Medicine 8th ed. New York: McGraw-Hill; in press.
    1. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res. 2003;16:208–214. - PubMed
    1. Kyriakis KP, Palamaras I, Tsele E, Michailides C, Terzoudi S. Case detection rates of vitiligo by gender and age. Int J Dermatol. 2009;48:328–329. - PubMed
    1. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview Part 1. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work up. J Am Acad Dermatol. 2011;65:473–491. - PubMed